Liean Schenck brings over 25 years of pharmaceutical industry experience in biologics process development, manufacturing, and CMC program management. Liean started her career at Lonza Biologics (UK) in fermentation development before spending more than 20 years at Eli Lilly and Company in various CMC roles, including several years within Lilly’s Chorus group. Liean is a dedicated leader in clinical delivery as well as commercial submissions, launches and post marketing product changes. Liean’s most recent role was the Head of CMC program management at Novavax.  Liean received an BSC in Microbiology with Biotechnology from University of Kent at Canterbury and a MSc in Biochemical Engineering from University College London.